INTUITIVE SURGICAL INC

Intuitive Surgical’s earnings reveal the future of surgical tech: market‑cap $144B, 49.44 P/E, and analyst‑surprise potential amid economic uncertainty.

Intuitive Surgical’s latest earnings beat forecasts, boosting its stock and reinforcing the demand for its robotic surgical systems.

Intuitive Surgical’s share price surged 448% in 10 years, topping $400 today, yet analysts debate its high PE and future growth amid market volatility.

Intuitive Surgical’s $147 bn market cap shows a tech‑driven growth story—5‑year gains hit 43 %, yet a DCF puts the stock at $196, raising the valuation debate. Explore the upside and risks of this surgical‑robotics leader.

Intuitive Surgical’s leadership shake‑up: Taylor Patton’s promotion to chief commercial officer boosts da Vinci and Ion growth, while Henry Charlton refines operations, positioning ISRG for aggressive expansion and investor confidence amid market di…

Intuitive Surgical Q1 2026 earnings beat shows da Vinci 5 drives 25 % revenue growth, 28 % margin, and strong analyst upside—growth story that’s hard to copy.

Intuitive Surgical’s Q1 2026 earnings may spark a turnaround as the company targets a growing robotic‑surgery market, focusing on sales velocity, repeat orders, and service revenue.

Intuitive Surgical’s latest quarter shows 19% revenue growth and 16% profit boost, yet its high 58× P/E sparks debate as analysts split on future value.

Intuitive Surgical’s latest market moves show strong institutional buying while an AI‑focused ETF trims its stake—highlighting tech gains and investor confidence.

Intuitive Surgical’s stock hits $499.53, backing a 169‑billion‑dollar healthcare tech giant whose earnings‑to‑price ratio of 62.5 signals strong, future‑growth potential for long‑term investors.